Company Filing History:
Years Active: 2025
Title: The Innovations of Stephen John Arkinstall
Introduction
Stephen John Arkinstall is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Arkinstall's work focuses on advancing therapeutic methods for cancer treatment.
Latest Patents
Arkinstall's latest patents include groundbreaking developments in antibodies. One of his key inventions is related to antibodies that bind to ICOS (Inducible T cell Co-Stimulator). This invention aims to modulate the ratio between regulatory T cells and effector T cells, thereby stimulating the immune system of patients. It holds potential for treating various cancers. Additionally, he has developed combinations of anti-ICOS antibodies with other drugs for immuno-oncology applications. Another significant patent involves anti-PD-L1 antibodies, which includes bispecific antibodies that target PD-L1 and immunocytokines that fuse an anti-PD-L1 antibody with a cytokine, such as IL-2. This invention also encompasses methods of treatment, uses, and pharmaceutical compositions that utilize these antibodies.
Career Highlights
Arkinstall is currently associated with Kymab Limited, where he continues to push the boundaries of immunological research. His work has been instrumental in developing therapies that enhance the immune response in patients, particularly in the context of cancer treatment.
Collaborations
Some of his notable coworkers include Jamie Iain Campbell and Nikole Sandy, who contribute to the innovative environment at Kymab Limited.
Conclusion
Stephen John Arkinstall's contributions to the field of immunology through his patents reflect his commitment to advancing medical science. His work not only showcases his inventive spirit but also holds promise for improving cancer therapies.